RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 53 filers reported holding RECRO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94 | -79.4% | 200 | -51.8% | 0.00% | – |
| Q2 2023 | $457 | -9.7% | 415 | -2.4% | 0.00% | – |
| Q1 2023 | $506 | -60.8% | 425 | -50.9% | 0.00% | – |
| Q4 2022 | $1,290 | +29.0% | 866 | -0.1% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 867 | -79.4% | 0.00% | – |
| Q2 2022 | $3,000 | +50.0% | 4,205 | +201.4% | 0.00% | – |
| Q1 2022 | $2,000 | -99.5% | 1,395 | -99.4% | 0.00% | – |
| Q4 2021 | $385,000 | -51.9% | 225,676 | -42.0% | 0.00% | – |
| Q3 2021 | $800,000 | -66.3% | 388,807 | -62.2% | 0.00% | – |
| Q2 2021 | $2,374,000 | +57.5% | 1,027,960 | +90.3% | 0.00% | – |
| Q1 2021 | $1,507,000 | +61.2% | 540,174 | +64.8% | 0.00% | – |
| Q4 2020 | $935,000 | +18600.0% | 327,776 | +15266.9% | 0.00% | – |
| Q3 2020 | $5,000 | -91.1% | 2,133 | -82.8% | 0.00% | – |
| Q2 2020 | $56,000 | -82.2% | 12,405 | -67.9% | 0.00% | – |
| Q1 2020 | $315,000 | -48.3% | 38,593 | +16.2% | 0.00% | – |
| Q4 2019 | $609,000 | -80.5% | 33,206 | -88.2% | 0.00% | -100.0% |
| Q3 2019 | $3,119,000 | +248.1% | 281,585 | +219.5% | 0.00% | – |
| Q2 2019 | $896,000 | +2321.6% | 88,135 | +1287.5% | 0.00% | – |
| Q1 2019 | $37,000 | -83.1% | 6,352 | -79.4% | 0.00% | – |
| Q4 2018 | $219,000 | -3.9% | 30,801 | -4.0% | 0.00% | – |
| Q3 2018 | $228,000 | +10.7% | 32,094 | -21.5% | 0.00% | – |
| Q2 2018 | $206,000 | -71.3% | 40,902 | -37.2% | 0.00% | – |
| Q1 2018 | $718,000 | +105.7% | 65,155 | +72.5% | 0.00% | – |
| Q4 2017 | $349,000 | -9.4% | 37,762 | -11.9% | 0.00% | – |
| Q3 2017 | $385,000 | +234.8% | 42,878 | +162.1% | 0.00% | – |
| Q2 2017 | $115,000 | +25.0% | 16,362 | +54.1% | 0.00% | – |
| Q1 2017 | $92,000 | -28.1% | 10,618 | -33.0% | 0.00% | – |
| Q4 2016 | $128,000 | +2460.0% | 15,850 | +2519.8% | 0.00% | – |
| Q3 2016 | $5,000 | -91.8% | 605 | -92.2% | 0.00% | – |
| Q2 2016 | $61,000 | -74.6% | 7,724 | -80.8% | 0.00% | – |
| Q1 2016 | $240,000 | -41.0% | 40,250 | -11.0% | 0.00% | – |
| Q4 2015 | $407,000 | -44.4% | 45,202 | -25.8% | 0.00% | – |
| Q3 2015 | $732,000 | +30.9% | 60,895 | +40.7% | 0.00% | – |
| Q2 2015 | $559,000 | +665.8% | 43,276 | +436.6% | 0.00% | – |
| Q1 2015 | $73,000 | – | 8,065 | +61938.5% | 0.00% | – |
| Q2 2014 | $0 | – | 13 | +44.4% | 0.00% | – |
| Q1 2014 | $0 | – | 9 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |